Matthew Feshbach's guest appearances

Matthew Feshbach

Blunt Force Truth

American Real

Gladden Longevity Podcast -- formerly Living Beyond 120

Suzanne Somers

Alan Hamel

Dan Sullivan

Kevin Wacasey

Shiva Ayyadurai

Perry Marshall

Matt Feshbach

Scott Nelson

David Thomas

Gino Wickman

Joe Polish

Steve Snyder

Tony Whatley

Evan Carmichael

Adam Winkler

OwlTail

Today’s show rundown:  The Big News from Mark is Earth Day was this past Friday.  Chuck tells us a little about what this stuff means to him and what he thinks about Global Warming.  They try to confuse pollution with climate change, Chuck thinks is a lie.  Well for earth day, Mark is going to drive his 36-thousand-pound motor home and trailer to a race track and burn 150 gallons of gas while ripping through a couple sets of tires. Mark introduces us to Matt Feshbach who is going to talk to us today about stem cells.  Stem Cells can be miraculous, they can be the biggest waste of money, but they have really opened the floodgates.  Chuck thinks most people think like he does, babies, infants, abortions…are we right to think this way?  Matt tells us it is completely different now, but embryonic stem cells are still indeed a thing.  Matt goes into explaining to people what a stem cell is.  It starts with the concept with a developmental cell.  When we are born, we have these perinatal cells.  Those cells are considered adult stem cells.  These cells are in every tissue in our body.  Fat underneath your skin is where you can harvest stem cells from.  Even if we are aging, and even if we are sick, we still have these healthy stem cells. https://ambrosecelltherapy.com/  Matt@ambrosecelltherapy.com 1-800-520-1746  About Matt Since 2018, Matthew "Matt" Feshbach has served as founding CEO of Ambrose Cell Therapy, a Florida-based center focused on improving the lives of people living with complex chronic health conditions. The center accesses a patient's own adipose-derived stem and regenerative cells (ADRCs), ADRCs have shown potential for treating chronic diseases affecting various areas of the body. Matthew Feshbach's interest in ADRCs dates back to 2009, when he began researching stem cells as part of his investment activities. His research led to the 2011 founding of Okyanos Cell Therapy, a center he led until 2017.  Prior to his work as a health care entrepreneur, Matt Feshbach found success as a hedge fund investor focused on a "short-only" strategy. Under his leadership, his investment company, Feshbach Brothers, grew from $20,000 to $1 billion in assets in only nine years. This led to the company being recognized by Piper Jaffray as the top-performing money manager over the period from 1985 to 1990.  Outside of his professional activities, Mr. Feshbach has worked to give back by supporting causes focused on human rights, religious freedom, and substance abuse. He also supports the Church of Scientology, an organization he has been a member of for five decades. His other free-time pursuits include cooking, swimming, and yoga.

Today’s show rundown:  The Big News from Mark is Earth Day was this past Friday. Chuck tells us a little about what this stuff means to him and what he thinks about Global Warming. They try to confuse pollution with climate change, Chuck thinks is a lie. Well for earth day, Mark is going to drive his 36-thousand-pound motor home and trailer to a race track and burn 150 gallons of gas while ripping through a couple sets of tires. Mark introduces us to Matt Feshbach who is going to talk to us today about stem cells. Stem Cells can be miraculous, they can be the biggest waste of money, but they have really opened the floodgates. Chuck thinks most people think like he does, babies, infants, abortions…are we right to think this way? Matt tells us it is completely different now, but embryonic stem cells are still indeed a thing.  Matt goes into explaining to people what a stem cell is. It starts with the concept with a developmental cell. When we are born, we have these perinatal cells. Those cells are considered adult stem cells. These cells are in every tissue in our body. Fat underneath your skin is where you can harvest stem cells from. Even if we are aging, and even if we are sick, we still have these healthy stem cells. <a href="https://ambrosecelltherapy.com/" rel="nofollow" target="_blank">https://ambrosecelltherapy.com/</a> Matt@ambrosecelltherapy.com 1-800-520-1746 About Matt Since 2018, Matthew "Matt" Feshbach has served as founding CEO of Ambrose Cell Therapy, a Florida-based center focused on improving the lives of people living with complex chronic health conditions. The center accesses a patient's own adipose-derived stem and regenerative cells (ADRCs), ADRCs have shown potential for treating chronic diseases affecting various areas of the body. Matthew Feshbach's interest in ADRCs dates back to 2009, when he began researching stem cells as part of his investment activities. His research led to the 2011 founding of Okyanos Cell Therapy, a center he led until 2017.  Prior to his work as a health care entrepreneur, Matt Feshbach found success as a hedge fund investor focused on a "short-only" strategy. Under his leadership, his investment company, Feshbach Brothers, grew from $20,000 to $1 billion in assets in only nine years. This led to the company being recognized by Piper Jaffray as the top-performing money manager over the period from 1985 to 1990.  Outside of his professional activities, Mr. Feshbach has worked to give back by supporting causes focused on human rights, religious freedom, and substance abuse. He also supports the Church of Scientology, an organization he has been a member of for five decades. His other free-time pursuits include cooking, swimming, and yoga.

Stem Cells and You – an Interview with Matthew Feshbach

Matthew Feshbach is the CEO of AMBROSE, pursuing his overarching purpose to help people with complex chronic diseases live better lives.  AMBROSE is providing the “right to try” cell therapy in accordance with the Right to Try Act, and, in complete alignment with their Mission: To help people with chronic degenerative diseases improve symptoms, function, and quality of life using adult stem cell therapy.   Matt took an unconventional path throughout his business career. He did not attend college, but instead taught tennis at private homes in Silicon Valley. Through that experience, he developed professional and personal relationships with some of the most prominent leaders in the San Francisco investment community.    In 1982, he co-founded Feshbach Bros, with his brothers Kurt and Joe. Feshbach Bros. managed the first “short-only” hedge fund, and assets under management grew from $20,000 to $1 Billion in 9 years.    In 2009, he and his brother, Joe, began researching adult stem cells and their potential due to their interest in a publicly-traded company. They spoke to researchers from all over the world – Israel to Japan, Holland to Spain, and New York to Los Angeles. Their quest was to understand the best source of adult stem cells, as well as the science, technologies, and unmet medical needs that could potentially be addressed with cell therapy.    Listen to the full story on today's episode of American Real. - If you're a knowledge expert, entrepreneur, business executive, or simply an aspiring author, connect with Roger to help you Write Your First Book in 90 Days or Less!    He's helping people all over the world write their first book - let him help you too. Watch his 10 minute presentation and schedule a call to discuss your book idea with him today: https://iywebinars.com/ar - Get Roger's latest book, "The Power of Being Rich: 10 Essential Steps to Manifest What You Already Have" by clicking on this link: https://amzn.to/2TN0sFr - Do you need a hand sorting through some uncertainty? Are you craving some accountability in your life? If you answered yes, book a call on Roger's calendar to see if he can help: https://calendly.com/americanreal/20min - Subscribe to our YouTube Channel: http://bit.ly/2zVQDLO - AMERICAN REAL  Website: https://americanreal.tv iTunes: https://apple.co/2yPeU4A Facebook: https://facebook.com/americanrealtv/ Instagram: https://www.instagram.com/AmericanRealTV Twitter: https://twitter.com/rogerbrooks/ LinkedIn: https://www.linkedin.com/in/rogerlbrooks/ YouTube: http://www.youtube.com/c/AmericanReal--- Support this podcast: https://anchor.fm/american-real/support

Matthew Feshbach is the CEO of AMBROSE, pursuing his overarching purpose to help people with complex chronic diseases live better lives.  AMBROSE is providing the “right to try” cell therapy in accordance with the Right to Try Act, and, in complete alignment with their Mission: To help people with chronic degenerative diseases improve symptoms, function, and quality of life using adult stem cell therapy. Matt took an unconventional path throughout his business career. He did not attend college, but instead taught tennis at private homes in Silicon Valley. Through that experience, he developed professional and personal relationships with some of the most prominent leaders in the San Francisco investment community.  In 1982, he co-founded Feshbach Bros, with his brothers Kurt and Joe. Feshbach Bros. managed the first “short-only” hedge fund, and assets under management grew from $20,000 to $1 Billion in 9 years.  In 2009, he and his brother, Joe, began researching adult stem cells and their potential due to their interest in a publicly-traded company. They spoke to researchers from all over the world – Israel to Japan, Holland to Spain, and New York to Los Angeles. Their quest was to understand the best source of adult stem cells, as well as the science, technologies, and unmet medical needs that could potentially be addressed with cell therapy.  Listen to the full story on today's episode of American Real. - If you're a knowledge expert, entrepreneur, business executive, or simply an aspiring author, connect with Roger to help you Write Your First Book in 90 Days or Less!  He's helping people all over the world write their first book - let him help you too. Watch his 10 minute presentation and schedule a call to discuss your book idea with him today: <a href="https://iywebinars.com/ar" rel="nofollow" target="_blank">https://iywebinars.com/ar</a> - Get Roger's latest book, "The Power of Being Rich: 10 Essential Steps to Manifest What You Already Have" by clicking on this link: <a href="https://amzn.to/2TN0sFr" rel="nofollow" target="_blank">https://amzn.to/2TN0sFr</a> - Do you need a hand sorting through some uncertainty? Are you craving some accountability in your life? If you answered yes, book a call on Roger's calendar to see if he can help: <a href="https://calendly.com/americanreal/20min" rel="nofollow" target="_blank">https://calendly.com/americanreal/20min</a> - Subscribe to our YouTube Channel: <a href="http://bit.ly/2zVQDLO" rel="nofollow" target="_blank">http://bit.ly/2zVQDLO</a> - AMERICAN REAL  Website: <a href="https://americanreal.tv" rel="nofollow" target="_blank">https://americanreal.tv</a> iTunes: <a href="https://apple.co/2yPeU4A" rel="nofollow" target="_blank">https://apple.co/2yPeU4A</a> Facebook: <a href="https://facebook.com/americanrealtv/" rel="nofollow" target="_blank">https://facebook.com/americanrealtv/</a> Instagram: <a href="https://www.instagram.com/AmericanRealTV" rel="nofollow" target="_blank">https://www.instagram.com/AmericanRealTV</a> Twitter: <a href="https://twitter.com/rogerbrooks/" rel="nofollow" target="_blank">https://twitter.com/rogerbrooks/</a> LinkedIn: <a href="https://www.linkedin.com/in/rogerlbrooks/" rel="nofollow" target="_blank">https://www.linkedin.com/in/rogerlbrooks/</a> YouTube: <a href="http://www.youtube.com/c/AmericanReal" rel="nofollow" target="_blank">http://www.youtube.com/c/AmericanReal</a>--- Support this podcast: <a href="https://anchor.fm/american-real/support" rel="nofollow" target="_blank">https://anchor.fm/american-real/support</a>

EPISODE #159 | MATTHEW FESHBACH | THE RIGHT TO TRY

Matthew Feshbach, founder and CEO of Ambrose Cell Therapy, joins the conversation to share information about stem cell research and treatment using stem cells. Feschbach explains the difference between types of stem cells and which are most effective for reparative therapies. They talk about why the body degenerates with age, related to stem cells.  Feshbach describes the process and technology his clinic uses to harvest mesenchymal stem cells for use in therapy. They consider some of the regulatory issues involved in stem cell therapy. Feshbach describes some of the amazing results that have been seen in patients who have received the therapy to treat significant health issues. He explains what sort of lifestyle choices can optimize results from this kind of treatment. Also on the podcast, Mark and Dr. Gladden discuss the problem with staying in your comfort zone, both physically and mentally. In contrast, they describe the environments in which we grow and thrive. Special Guest: Matthew (Matt) Feshbach is the Founder and CEO of AMBROSE Cell Therapy. AMBROSE was founded in 2017 with the mission: To help people with chronic degenerative diseases improve symptoms, function and quality of life with adult stem cell therapy. Matt has taken an unconventional path throughout his business career. He did not attend college but instead taught tennis at private homes in Silicon Valley. Through that experience he developed professional and personal relationships with a number of prominent investment managers, who inspired him to study securities analysis and begin investing himself. This led to the co-founding, with his brothers Kurt and Joe, of Feshbach Bros in 1982. Feshbach Bros. managed the first “short-only” hedge fund. Assets under management grew from $20,000 to $1 Billon in 9 years. Matt’s investment career, through the ups and downs of the stock market, spanned more than 30 years. In 2009 he and his brother, Joe, began researching adult stem cells and their potential, due to their interest in a publicly traded company. They spoke to researchers from all over the world - Israel to Japan, Holland to Spain, New York to Los Angeles, Chicago to Dallas and so on - to understand the best source of adult stem cells as well as the science, technologies and unmet medical needs they could potentially address. As a result of their research, they came to have a well-informed opinion that fat (adipose) tissue is the most accessible, abundant and potent source of adult stem and regenerative cells. As well, that the mixed population of adipose-derived stem and regenerative cells (ADRCs) could be used to address a broad spectrum of chronic diseases. This has now been validated in the published medical literature. 1 2 3 Along with his brother, Matt founded Okyanos (Oh-key-ah-nos) Cell Therapy in August 2011 in Freeport, Bahamas. The Greek God of Rivers, “Okyanos” symbolizes restoration of blood flow, which is an important mechanism of action of ADRCs. Shortly after helping to create Okyanos, Matt’s brother, Joe, sadly died of a cardiac arrest. Joe’s death prompted Matt to be even more dedicated his purpose to help patients with chronic disease with their own adult stem cells. In the Bahamas, he drafted the framework for what developed into the Bahamas Stem Cell Research and Therapy Act, while concurrently building and staffing Okyanos. Due to the uncompromising standards set by Matt, Okyanos came to be known as the first cell therapy center of excellence in the world. The passage of House Bill 810, Charlie’s Law, in Texas paved the way for Matt to once again set a new standard in cell therapy for complex chronic disease. To be specific, Charlie’s Law allows the use of investigational adult stem cell treatments in Texas for patients that have been diagnosed with a terminal illness or severe chronic disease. This is a Right-to-Try Law. The U.S Constitution - Tenth Amendment states - “The powers not delegated to the United States by the Constitution, nor prohibited by it to the States, are reserved to the States respectively, or to the people.”   As such FDA has not taken action against drug companies or providers in the 28 states with medical marijuana laws and the 38 states with laws allowing patients who are terminally ill the right to try experimental drugs without FDA approval (Right to try Laws), respectively.   Matthew Feshbach has combined his 3 decades of investment experience with his personal purpose to help others and, for a non-medical person, extraordinary knowledge of the science, technology and protocols of adult stem cell therapy to bring the highest standards of safety, care and potential effectiveness to patients in need. 1 A Nguyen, A et al Stromal vascular fraction: A regenerative reality? Part 1: Current concepts and review of the literature Journal of Plastic, Reconstructive &amp; Aesthetic Surgery (2016) 69, 170e179 2 Guo et al Stromal vascular fraction: A regenerative reality? Part 2: Current concepts and review of the literature Journal of Plastic, Reconstructive &amp; Aesthetic Surgery (2016) 69, 180e188 3 JK Fraser PhD and S Kesten MD Autologous Adipose Derived Regenerative Cells: A platform for therapeutic applications Advanced Wound Healing Surgical Technology International XXIX You can contact Feschbach via email or by phone: matt@ambrosecelltherapy.com (727) 743-1510

Matthew Feshbach, founder and CEO of Ambrose Cell Therapy, joins the conversation to share information about stem cell research and treatment using stem cells. Feschbach explains the difference between types of stem cells and which are most effective for reparative therapies. They talk about why the body degenerates with age, related to stem cells.  Feshbach describes the process and technology his clinic uses to harvest mesenchymal stem cells for use in therapy. They consider some of the regulatory issues involved in stem cell therapy. Feshbach describes some of the amazing results that have been seen in patients who have received the therapy to treat significant health issues. He explains what sort of lifestyle choices can optimize results from this kind of treatment. Also on the podcast, Mark and Dr. Gladden discuss the problem with staying in your comfort zone, both physically and mentally. In contrast, they describe the environments in which we grow and thrive. Special Guest: Matthew (Matt) Feshbach is the Founder and CEO of AMBROSE Cell Therapy. AMBROSE was founded in 2017 with the mission: To help people with chronic degenerative diseases improve symptoms, function and quality of life with adult stem cell therapy. Matt has taken an unconventional path throughout his business career. He did not attend college but instead taught tennis at private homes in Silicon Valley. Through that experience he developed professional and personal relationships with a number of prominent investment managers, who inspired him to study securities analysis and begin investing himself. This led to the co-founding, with his brothers Kurt and Joe, of Feshbach Bros in 1982. Feshbach Bros. managed the first “short-only” hedge fund. Assets under management grew from $20,000 to $1 Billon in 9 years. Matt’s investment career, through the ups and downs of the stock market, spanned more than 30 years. In 2009 he and his brother, Joe, began researching adult stem cells and their potential, due to their interest in a publicly traded company. They spoke to researchers from all over the world - Israel to Japan, Holland to Spain, New York to Los Angeles, Chicago to Dallas and so on - to understand the best source of adult stem cells as well as the science, technologies and unmet medical needs they could potentially address. As a result of their research, they came to have a well-informed opinion that fat (adipose) tissue is the most accessible, abundant and potent source of adult stem and regenerative cells. As well, that the mixed population of adipose-derived stem and regenerative cells (ADRCs) could be used to address a broad spectrum of chronic diseases. This has now been validated in the published medical literature. 1 2 3 Along with his brother, Matt founded Okyanos (Oh-key-ah-nos) Cell Therapy in August 2011 in Freeport, Bahamas. The Greek God of Rivers, “Okyanos” symbolizes restoration of blood flow, which is an important mechanism of action of ADRCs. Shortly after helping to create Okyanos, Matt’s brother, Joe, sadly died of a cardiac arrest. Joe’s death prompted Matt to be even more dedicated his purpose to help patients with chronic disease with their own adult stem cells. In the Bahamas, he drafted the framework for what developed into the Bahamas Stem Cell Research and Therapy Act, while concurrently building and staffing Okyanos. Due to the uncompromising standards set by Matt, Okyanos came to be known as the first cell therapy center of excellence in the world. The passage of House Bill 810, Charlie’s Law, in Texas paved the way for Matt to once again set a new standard in cell therapy for complex chronic disease. To be specific, Charlie’s Law allows the use of investigational adult stem cell treatments in Texas for patients that have been diagnosed with a terminal illness or severe chronic disease. This is a Right-to-Try Law. The U.S Constitution - Tenth Amendment states - “The powers not delegated to the United States by the Constitution, nor prohibited by it to the States, are reserved to the States respectively, or to the people.” As such FDA has not taken action against drug companies or providers in the 28 states with medical marijuana laws and the 38 states with laws allowing patients who are terminally ill the right to try experimental drugs without FDA approval (Right to try Laws), respectively. Matthew Feshbach has combined his 3 decades of investment experience with his personal purpose to help others and, for a non-medical person, extraordinary knowledge of the science, technology and protocols of adult stem cell therapy to bring the highest standards of safety, care and potential effectiveness to patients in need. 1 A Nguyen, A et al Stromal vascular fraction: A regenerative reality? Part 1: Current concepts and review of the literature Journal of Plastic, Reconstructive &amp; Aesthetic Surgery (2016) 69, 170e179 2 Guo et al Stromal vascular fraction: A regenerative reality? Part 2: Current concepts and review of the literature Journal of Plastic, Reconstructive &amp; Aesthetic Surgery (2016) 69, 180e188 3 JK Fraser PhD and S Kesten MD Autologous Adipose Derived Regenerative Cells: A platform for therapeutic applications Advanced Wound Healing Surgical Technology International XXIX You can contact Feschbach via email or by phone: <a href="mailto:matt@ambrosecelltherapy.com">matt@ambrosecelltherapy.com</a> (727) 743-1510

Stem Cell Therapy Now – an Interview with Matthew Feshbach – Episode 26